Mylan licenses rights to produce and market generic versions of Gilead HIV/AIDS therapies
01:55 EDT 3 Aug 2012 | The Medical News
Mylan Inc. today announced the establishment of a new agreement between its subsidiary Mylan Laboratories Limited and Gilead Sciences Inc. Under this agreement, Mylan has licensed the rights to produce and market generic versions of Gilead HIV/AIDS t..
Original Article: Mylan licenses rights to produce and market generic versions of Gilead HIV/AIDS therapies
More From BioPortfolio on "Mylan licenses rights to produce and market generic versions of Gilead HIV/AIDS therapies"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
